comparemela.com

Medfocus Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Irish medtech company Perfuze raises €22 5m for new stroke treatment

Company developing catheter-based technology to facilitate fast clot removal

Daniel omahonyMegan macdonaghSv healthSeroba life sciencesWorld health organisationIrish timesMedfocus fundDanielo mahonyHarma medtechAnne portwichDanielo mahonyLiam mullinsMegan macdonaghDwayne allenEnterprise irelandWorld health organization

Irish medtech company Perfuze raises €22 5m for stroke treatment device

Perfuze is developing catheter-based technology to remove blood clots from the brain in one pass to treat acute ischemic stroke.

Dwayne allenMatt crockettMedtech company of the yearEuropean innovation councilSv health investorsDrug administrationSeroba life sciencesMedfocus fundEnterprise irelandPerfuze millipede systemEuropean innovationEmerging medtech companyBeaumont hospital dr matt crockett

Advertiser ie - Galway-based neurovascular company Perfuze raises €22 5m Series A investment for new stroke treatment

Perfuze, a Galway-based medical device company developing next-generation catheter-based aspiration technology to treat large vessel occlusion acute ischemic stroke, has closed a €22.5 million Series A investment round.

Daniel omahonyMegan macdonaghAnne portwichDwayne allenHealth economics fundPartner at seroba life sciencesSv health investorsMedtech convergence fundSv healthSeroba life sciencesEconomics fundSeroba lifeMedfocus fundEnterprise irelandDanielo mahonySenior associate

vimarsana © 2020. All Rights Reserved.